RT @Jimweston77: Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients | Journal of Translational…
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients https://t.co/cBAK9w6be6 #stemcells #adipose #COVID19 #CoronavirusFacts
RT @iofoundation: IOF Member Chris Rogers, M.D. will be presenting #regenerativemedicine strategies to combat COVID-19 at @TOBIConference.…
RT @iofoundation: IOF Member Chris Rogers, M.D. will be presenting #regenerativemedicine strategies to combat COVID-19 at @TOBIConference.…
RT @iofoundation: IOF Member Chris Rogers, M.D. will be presenting #regenerativemedicine strategies to combat COVID-19 at @TOBIConference.…
IOF Member Chris Rogers, M.D. will be presenting #regenerativemedicine strategies to combat COVID-19 at @TOBIConference. Use the code IOF100 for $100 off of your registration.
RT @TOBIConference: Featured at #TOBIVIRTUAL is a unique session on COVID-19 and the regenerative medicine strategies being used to combat…
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients: Journal of Translational Medicine https://t.co/2euQ7ANEvk
RT @TOBIConference: Featured at #TOBIVIRTUAL is a unique session on COVID-19 and the regenerative medicine strategies being used to combat…
Featured at #TOBIVIRTUAL is a unique session on COVID-19 and the regenerative medicine strategies being used to combat it. One of those talks will be by TOBI alumni, Dr. Chris Rogers, presenting on his new work combating COVID-19 with MSCs. Full pub👉 https
$PSTI technical papers shows the Pluristem advantage... https://t.co/kxZjSABaRd https://t.co/W58UNqubb2 https://t.co/DHdpF7Ipib (#Pluristem uses intramuscular)